South Lyon Hospital Center

Lyon 69495

1 studies enrolling now · 5 studies all time

What they study most

Acute Myeloid Leukemia, MF, Multiple Myeloma, Myelofibrosis, Post-ET Myelofibrosis, Post-PV MF, Primary Myelofibrosis, SCC - Squamous Cell Carcinoma of Skin, Short Bowel Syndrome

Studies at this site

• Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib — Recruiting now
• Open-label Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short Bowel Syndrome. — Running, not enrolling
• Non-comparative Study of IFX-1 Alone or IFX-1+Pembrolizumab in Patients With Locally Advanced or Metastatic cSCC. — Stopped early
• Bortezomib, Selinexor, and Dexamethasone in Patients With Multiple Myeloma — Completed
• TL-895 and KRT-232 Study in Acute Myeloid Leukemia — Status unconfirmed